• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

How eClinicalWorks Agentic AI Is Helping Revenue Cycle Leaders Improve Financial Performance
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

American College of Cardiology Recommends GLP-1s as First Line Treatment Option

by Fred Pennic 06/20/2025 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know: 

– The American College of Cardiology (ACC) has published a new Concise Clinical Guidance (CCG) report, providing a comprehensive framework for clinicians to medically manage obesity using the “ever-expanding set of tools to assist patients in diagnosis, weight reduction, and CVD risk mitigation.”

– The new guidance, published in the Journal of the American College of Cardiology (JACC), addresses the multiple causes of obesity and outlines a clinical decision-making process for incorporating modern pharmacologic weight management strategies into cardiovascular care.

A Framework for a Complex, Chronic Disease

The CCG acknowledges the multifaceted nature of obesity, highlighting its multiple causes, which include genetic, neurological, psychological, environmental, and social factors. It also emphasizes the strong link between obesity and cardiovascular disease risks such as sleep apnea, dyslipidemia, hypertension, and type 2 diabetes. The guidance is designed to help clinicians navigate the use of modern obesity medications, which can offer significant benefits with fewer risks than some procedure-based interventions.

Key Pillars of the New Guidance

The clinical decision-making framework outlined in the CCG highlights several key areas for clinicians to consider:

  • Rationale and Eligibility: The guidance notes that pharmacotherapy strikes a crucial balance between effectiveness and invasiveness. Eligibility for these treatments may be determined by BMI thresholds or other cardiovascular risk indicators.
  • Pharmacological Options: Among U.S. Food and Drug Administration-approved medications, the GLP-1 receptor agonist semaglutide and the GLP-1/GIP receptor agonist tirzepatide have demonstrated the highest efficacy. The guidance acknowledges that insurance coverage, availability, and affordability will likely be key factors in agent selection.
  • Impact on Cardiovascular Risk: The report cites clinical evidence supporting that these medications lead to a reduction in major adverse cardiovascular events (MACE), including cardiovascular death, myocardial infarction, and stroke, particularly in individuals with type 2 diabetes and elevated cardiovascular risk.
  • Multidisciplinary Care Approaches: The CCG emphasizes that team-based approaches are critical for effective weight management. This includes assessing modifiable risk factors, identifying comorbidities, and tailoring treatment strategies to the individual patient.
  • Reducing Bias and Improving the Patient Experience: The guidance calls on clinicians to validate the lifelong journey that patients experience with obesity. This includes using person-first language, creating welcoming clinical environments, and actively addressing weight stigmas.
  • Access Considerations: The report recognizes that a lack of insurance coverage remains a major barrier for patients. It suggests that initial strategies to improve access should include identifying individuals most likely to benefit from these therapies, closely monitoring treatment outcomes, and engaging in price negotiations.
  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: GLP-1

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

How eClinicalWorks Agentic AI Is Helping Revenue Cycle Leaders Improve Financial Performance

Most-Read

Innovaccer-CHIME 2030 Survey Reveals AI Will Automate Nearly Two-Thirds of Administrative Work and Do 3x the Work With the Same Staff

Innovaccer-CHIME 2030 Survey Reveals AI Will Automate Nearly Two-Thirds of Administrative Work and Do 3x the Work With the Same Staff

CB Insights’ 2026 Digital Health 50 Reveals How Agentic AI Is Becoming the Clinical Provider and Medication Access Engine

Oura Acquires Counsel Health for $625M: Scaling Continuous Biometrics into On-Demand Medical Care

M&A: Oura Acquires Counsel Health for $625M: Scaling Continuous Biometrics into On-Demand Medical Care

WittKieffer 2026 Healthcare CIO Survey: 82% Sit on Executive Teams, Yet Only 36% Have Formal Succession Plans

WittKieffer 2026 Healthcare CIO Survey: 82% Sit on Executive Teams, Yet Only 36% Have Formal Succession Plans

CVS Rebrands Health Services Segment, Launches Model for Retail Pharmacy Reimbursement

CVS Health Formalizes Tax-Free Split-Off to Carve Out CVS Pharmacy by 2028

SAMHSA and ONC Invest $20M in Behavioral Health IT Initiative

ONC Finalizes HTI-5 Deregulatory Rule to Cut $1.55B in Health IT Compliance and Accelerate FHIR APIs

Redesign Health Merges with Sheba Medical Center’s ARC Global and Agrees to Acquire AVIA

Redesign Health Merges with Sheba Medical Center’s ARC Global and Agrees to Acquire AVIA

Sword Acquires Headspace in All-Cash Deal Worth Up to $300M to Unify Physical and Mental AI Care

M&A: Sword Acquires Headspace in All-Cash Deal Worth Up to $300M to Unify Physical and Mental AI Care

M&A: Francisco Partners to Acquire Weave in $650M Take-Private Deal

M&A: Francisco Partners to Acquire Weave in $650M Take-Private Deal

Epic Launches One-Click Care Everywhere Diagnostic Image Exchange

Epic Launches One-Click Care Everywhere Diagnostic Image Exchange

Secondary Sidebar

Footer

Company

  • About Us
  • 2026 Editorial Calendar
  • Advertise with Us
  • Reprints and Permissions
  • Op-Ed Submission Guidelines
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2026. HIT Consultant Media. All Rights Reserved. Privacy Policy |